Better Medicine

Better Medicine is transforming cancer diagnostics with innovative AI solutions that support early detection and efficient monitoring across the entire body. Our focus on full-body oncology imaging ensures comprehensive cancer detection and tracking, providing radiologists with the tools they need to diagnose with confidence.

At the core of Better Medicine’s approach is its mission to give radiologists “superpowers.” The company’s technology goes beyond improving individual workflows—it optimizes oncology imaging processes on a systemic level. By combining AI with human-guided, one-click automation, our solutions enhance radiologists’ capabilities, offering automatic lesion detection while streamlining workflows for lesion tracking and longitudinal assessment during follow-up. This enables more efficient diagnostic processes and greater precision in imaging analysis.

Clinically validated and trusted by healthcare professionals worldwide, Better Medicine upholds the highest quality standards, including ISO 13485 certification and the world’s first CE-marked AI for kidney lesion detection.

Role of institution in the project

The data received via EUCAIM will be used to develop and clinically validate Better Medicine’ multi organ and multi cancer AI detection and quantification model covering primary tumors and metastatic spread. The company contributes to WP-7.

Dmytro Fishman

In addition to being the Chief Science Officer & Co-Founder at Better Medicine, Dmytro is also an Associate Professor of Artificial Intelligence and Head of the Biomedical Computer Vision Lab at the University of Tartu. Dmytro has earned various recognitions, including Ustus Agur Scholarship, second-best PhD thesis in the subject of Science and Technology in Estonia, Badge of Distinction, awarded for outstanding job achievements and significant contribution to the activities of the university, several times voted the best teacher and in 2023 has been named Young IT Scientist of the year in Estonia.

Bohdan Petryshak

Bohdan is the Chief of AI Engineering & Co-Founder at Better Medicine. Bohdan’s background is in medical computer vision engineering - an area where he has a decade worth of experience. In addition, Bohdan is a Co-founder of the Data Engineering Certification program at Ukrainian Catholic University and a PhD student in Computer Science faculty at Tartu University. At Better Medicine, Bohdan leads the AI department and interdisciplinary team of AI engineers and radiologists. Before creating Better Medicine, Bohdan co-founded another MedTech startup CardioVision.

Priit Salumaa

Priit is the CEO and Co-founder at Better Medicine. Priit has profound experience in the technology sector - his background is in software engineering and he has created and been part of building various tech companies over the last 25 years. Priit is also one of the key members of Estonian startup community initiating a series of non-profits like Garage48 Foundation, Latitude59 and Solaride. When the pandemic hit, he switched to medicine and started Better Medicine with a team passionate to improve things for both patients and doctors.

Join the EUCAIM Consortium

Open Call for New Beneficiaries

We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.

Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.

Apply by 10 June 2024!

Find out more

Open Call Webinar

We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.

WATCH THE RECORDING

Our open Call for new collaborators
launches in April 2024

Opportunities for data holders & AI developers to contribute await! Let‘s join forces to enhance cancer diagnosis and treatment

Be the first to know and apply!

Sign up for more information

SAVE THE DATE
March 14, 10:00-11:30 aM CET

DISCOVER THE CANCER IMAGE EUROPE PLATFORM

TECHNICAL DEMONSTRATION WEBINAR

Explore the potential for AI-driven cancer care advancements!
Learn how to access and utilize our federated cancer image repository. The webinar is for AI Innovators & Data Providers interested in the platform and will feature an introduction to EUCAIM & Cancer Image Europe and a demonstration of data exploration & access.

Survey Invitation

Join Leading Experts In Shaping AI In Cancer

EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.

Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.

Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.

Participate